Mo1733 EFFECTS OF EXCLUSIVE ENTERAL NUTRITION WITH LIQUID DIET ON GUT MICROBIOTA COMPOSITION AND DIVERSITY IN A RAT MODEL OF CROHN'S-LIKE COLITIS
Leggi →
Maggio 2024
Risultati per: Microbiota e barriera intestinale distanti ma non troppo: implicazioni metaboliche sistemiche
Questo è quello che abbiamo trovato per te
Tu1644 LONG-TERM EFFICACY AND SAFETY OF ENCAPSULATED FECAL MICROBIOTA TRANSPLANTATION (FMT) AND FMT VIA RECTAL ENEMA FOR IRRITABLE BOWEL SYNDROME (IBS): A PROSPECTIVE COHORT STUDY
Leggi →
Maggio 2024
Mo1739 VAGINAL MICROBIOTA DIVERSITY OF PREGNANT INDIVIDUALS IS STRONGLY ASSOCIATED WITH HEALTHIER DIETS AND SUBTLE ASSOCIATED WITH INFLAMMATORY MARKERS, REGARDLESS OF IBD STATUS
Leggi →
Maggio 2024
62 RANDOMIZED CONTROLLED TRIAL ON ORAL ADMINISTRATION OF LACTOBACILLUS CASEI DG FOR 8 WEEKS AFTER ILEOSTOMY CLOSURE (MICROBIOTA AND IMMUNE (MICROENVIRONMENT IN POUCHITIS.-MEP1- NCT03136419).
Leggi →
Maggio 2024
EP48 THE IMPACT OF CHEMORADIOTHERAPY ON ORAL AND GUT MICROBIOTA IN PATIENTS WITH ESOPHAGUS CANCER
Leggi →
Maggio 2024
Mo1920 EFFICACY OF VONOPRAZAN TRIPLE THERAPY COMBINED WITH ENCAPSULATED FECAL MICROBIOTA TRANSPLANTATION (FMT) AS ADJUVANT FOR HELICOBACTER PYLORI ERADICATION: A DOUBLE-BLIND, RANDOMIZED, PLACEBO-CONTROLLED STUDY (FMT-HP TRIAL)
Leggi →
Maggio 2024
Mo1914 COMPREHENSIVE MICROBIOME PROFILING REVEALS GUT MICROBIOTA HETEROGENEITY IN CRC PATIENTS WITH DIFFERENT TUMOR LOCATIONS
Leggi →
Maggio 2024
Mo1908 INCREASING SIMILARITY OF MICROBIOTA COMPOSITIONS BETWEEN ORAL AND GASTRIC SAMPLES DURING GASTRIC CARCINOGENESIS
Leggi →
Maggio 2024
Mo1794 CROHN'S DISEASE-ASSOCIATED PATHOGENIC MUTATION IN MANGANESE TRANSPORTER ZIP8 SHIFTS THE ILEAL AND RECTAL MUCOSAL MICROBIOTA IMPLICATING ABERRANT BILE ACID METABOLISM
Leggi →
Maggio 2024
Mo1800 CMTM4 ALLEVIATES COLITIS VIA THE IL-17RC-S100A8/9-GUT MICROBIOTA AXIS
Leggi →
Maggio 2024
Tu1775 UNVEILING METABOLITE-MICROBIOTA CROSSTALK IN A MURINE MODEL OF CHECKPOINT INHIBITOR-INDUCED COLITIS
Leggi →
Maggio 2024
Tu1919 IMPROVEMENT OF INSULIN RESISTANCE FOLLOWING FECAL MICROBIOTA TRANSPLANTATION: SYSTEMATIC REVIEW AND META-ANALYSIS OF RANDOMIZED CONTROLLED TRIALS
Leggi →
Maggio 2024
Tu1920 FECAL MICROBIOTA TRANSPLANT ENEMA AS A PROMISING TREATMENT IN METABOLIC SYNDROME: A RANDOMIZED DOUBLE-BLIND PLACEBO-CONTROLLED TRIAL
Leggi →
Maggio 2024
EP117 THE EFFECT OF LACTOBACILLUS RHAMNOSUS GG ON THE GLP-1/GLP-1R AXIS AND GUT MICROBIOTA IN OBESE MICE
Leggi →
Maggio 2024
943 THE MICROBIOTA AT THE TIME OF SURGERY IS SIGNIFICANTLY ENRICHED WITH PRO-TUMORIGENIC BACTERIA IN PATIENTS WHO DEVELOP A POSTOPERATIVE RECURRENCE
Leggi →
Maggio 2024
Fecal microbiota transplantation for recurrent C. difficile infection can be the best therapeutic option in severely immunocompromised patients depending on a case-by-case assessment of the benefit/risk ratio
Leggi →
Aprile 2024
